Angela Santoni

Pubblicazioni

Titolo Pubblicato in Anno
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay JOURNAL OF HEMATOLOGY & ONCOLOGY 2016
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells ONCOIMMUNOLOGY 2016
Regulation of NKG2D Expression and Signaling by Endocytosis TRENDS IN IMMUNOLOGY 2016
NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2 IMMUNOLOGY LETTERS 2016
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression JOURNAL OF IMMUNOLOGY 2016
Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients. ONCOTARGET 2016
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases. FRONTIERS IN IMMUNOLOGY 2016
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy CRITICAL REVIEWS IN IMMUNOLOGY 2016
Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice Nature CommunicationsNATURE COMMUNICATIONS 2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients ONCOIMMUNOLOGY 2015
NK cells and interferons CYTOKINE & GROWTH FACTOR REVIEWS 2015
Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients. HAEMATOLOGICA 2015
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma BIOMED RESEARCH INTERNATIONAL 2015
The multifaceted role of PIP2 in leukocyte biology CELLULAR AND MOLECULAR LIFE SCIENCES 2015
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma ONCOTARGET 2015
Response to comment on multifunctional human CD56<sup>low</sup>CD16<sup>low</sup> NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients HAEMATOLOGICA 2015
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells CANCER RESEARCH 2015
In Vivo Imaging of Natural Killer Cell Trafficking in Tumors THE JOURNAL OF NUCLEAR MEDICINE 2015
The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro JOURNAL OF IMMUNOTHERAPY 2015
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells. ONCOTARGET 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma